Summit Financial »

Eledon Pharmaceuticals shares owned by Summit Financial

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Summit Financial from 13F filings

Historical chart of Summit Financial investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Summit Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Summit Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $30k 12k 2.59

More positions owned by Summit Financial

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Summit Financial

Top funds holding Eledon Pharmaceuticals

BVF
RA Capital Management
BlackRock
Vanguard Group
Siren
Zimmer Partners
Sphera Funds Management
Geode Capital Management
Wellington Management Company
Ensign Peak Advisors
Nantahala Capital Management
Catalio Capital Management
Blue Owl Capital Holdings
Sanofi
Woodline Partners

View all funds holding Eledon Pharmaceuticals